Developing countries

English

The global health and economic impact of tobacco

Tobacco kills half of its regular users, exacts a considerable toll in terms of disease, disability and suffering, and has a profoundly negative impact on family incomes and national economies. In this article, Derek Yach emphasizes the size of these impacts globally and in particular in China.

Restoring diabetes care in Rwanda: the need for effective partnerships

In 1994, more than one million people died in Rwanda in one of the worst genocides in modern times. Rwandan society, at all levels including healthcare, continues to count the human and financial costs of the tragedy – a burden which is compounded by the debilitating scarcity of resources in the nation as a whole. Most of Rwanda’s 8 200 000 inhabitants are united by poverty: according to figures published by the World Bank, the yearly per capita income in Rwanda is 220 USD.

Focus on the people

President's editorial

Socio-economic determinants of the costs of diabetes in India

Diabetes is rapidly emerging as a major health-care problem in India, especially in urban areas where the prevalence of Type 2 diabetes has been reported as 12% of the adult population. Furthermore, there is an equally large pool of people with

Diabetes under fire

In the last issue of Diabetes Voice Panagiotis Tsapogas presented a view of diabetes care in Gaza from the perspective of his work with Médecins Sans Frontières. Here, Itamar Raz, President of the Israel Diabetes Association (IDA), presents a view from the perspective of an Israeli person living in the region, and from the leading Palestinian physicians with whom he collaborates. Together they struggle in the midst of the disruptions to deliver diabetes health care across the

The human perspective on health-care reform: coping with diabetes in Kyrgyzstan

Kyrgyzstan is a small mountainous country with a predominantly agricultural economy; it gained independence with the break-up of the Soviet Union in 1991. For a significant sector of the Kyrgyzstani population, economic difficulties at national level translate into high unemployment and widespread impoverishment. Kyrgyzstan inherited an extensive but basic health-care system, with a functioning – albeit fragmented – structure for managing chronic diseases.

Cost and availability of insulin and other diabetes supplies: IDF survey 2002-2003

Insulin is a life-sustaining medication and as such has been designated an ‘essential drug’ by the World Health Organization (WHO). Insulin therefore should be universally available to everyone who requires it for survival. However, accessibility to the drug is often not secure. This results in life-threatening complications for people who depend on insulin for survival. The authors of this article, in reporting on the results of the International Diabetes Federation (IDF) survey, 2002-2003, make a call for improvements to the pricing and availability

Diabetes care in need

Editor-in-Chief's editorial

Diabetes in times of crisis

President's editorial

Plans to stop animal insulin production. Bad news for developing countries

For the West, the availability of animal insulin is a question of freedom of choice. However, it is the only way of survival for a number of people with diabetes in the developing world. Will the plea for help from the people with diabetes in the developing countries, in search of life, go unnoticed, unheard?

Pages